Allopurinol for Depression in Adults on Sertraline
Official title: Allopurinol Adjuvant Therapy in Patients With Major Depressive Disorder
Run by Tanta University · NCT07574060 · Data updated 2026-11-12
This trial tests whether adding allopurinol to sertraline helps adults with major depressive disorder who haven’t fully responded to first-line treatment.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Status | Recruiting |
| Started | May 20, 2026 |
| Main results expected | May 20, 2027 |
| Study ends | May 20, 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07574060 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with major depressive disorder who have a HAM-D score of at least 10 and are not diagnosed with bipolar disorder or the specified exclusions.
✕Probably not a fit
Patients with bipolar disorder, pregnancy, significant cardiovascular or kidney disease, eating disorders, or those not able to take birth control may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and effectiveness of combining allopurinol with sertraline in adults with major depressive disorder. Participants will receive sertraline 50 mg plus allopurinol 300 mg and will be monitored for changes in depressive symptoms and tolerability. The trial includes adults with a HAM-D score of 10 or higher and excludes those with bipolar disorder, eating disorders, pregnancy, cardiovascular issues, or severe kidney problems. It is conducted at Tanta University under a non-commercial collaboration.
Why it matters
Potential benefit: If successful, this combination could offer a new option for patients who do not fully respond to standard antidepressants.
How similar studies have gone: There is limited published data on allopurinol added to antidepressants, so this study explores a relatively novel combination.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients aged greater than 18 years old. Patients with a HAM-D score of at least 10 with item 1, depressed mood, scoring 2 or greater, are eligible. Exclusion Criteria: Patients with bipolar I or bipolar II disorder Patients with eating disorders Pregnant women or women not using medically accepted means of birth control Cardiovascular disorders Severe renal impairment
Where it's running
-
Tanta Unuversity
Tanta, Egypt Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.